entity

Proteinopathy

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Proteinopathy: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

2Connections
6Hypotheses
0Analyses
0Outgoing
2Incoming
0Experiments
0Debates

No AI portrait yet

Wiki Pages (15)

Knowledge base pages for this entity

Validated Hypothesis: Microglial AIM2 Inflammasome as the Primary Driver of TDP-43 Proteinopathy Neuroinflammation in ALS/FTD

hypothesis · 5607 words

TDP-43 Proteinopathy

mechanism · 4112 words

TDP-43 Proteinopathy in Amyotrophic Lateral Sclerosis

mechanism · 3471 words

Dual Proteinopathy Immunotherapy: Aβ + pTau/pα-Syn Bispecific

idea · 2414 words

TDP-43 Proteinopathy in ALS

mechanism · 1751 words

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (2)

SourceRelationTypeStr
CCDC50protects_againstgene0.80
TDP-43associated_withprotein0.70

Targeting Hypotheses (6)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Microglial AIM2 Inflammasome as the Primary Driver of TDP-43 0.824 neurodegeneration What are the mechanisms by which gut mic
NLRP3 inflammasome amplification across AD and PD proteinopa 0.800 multi Cross-disease neurodegeneration mechanis
TDP-43 Proteinopathy as a Cross-Disease Pathological Substra 0.760 neurodegeneration Cross-disease neurodegeneration mechanis
Pericyte senescence is sufficient to weaken the BBB even wit 0.630 neurodegeneration Does pericyte senescence drive BBB break
TREM2-mediated PV interneuron stabilization to restore gamma 0.583 neurodegeneration -
Dual Proteinopathy Clearance via Enhanced Drainage 0.000 - Perivascular spaces and glymphatic clear

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (9)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiqui [PMID:30966861] ["Han X", "Sun S", "Sun Y", "Song Q", "Z Autophagy 2020 1
Interaction between autophagy and the NLRP3 inflammasome in Alzheimer's and Park [PMID:36262883] Unknown Frontiers in aging neuroscienc 2023 0
Inhibition of autophagy in microglia and macrophages exacerbates innate immune r [PMID:36652438] Hegdekar N, Sarkar C, Bustos S, Ritzel R Autophagy 2023 0
Inflammasome assembly in neurodegenerative diseases. [PMID:37633753] Singh J, Habean ML, Panicker N Trends in neurosciences 2023 0
NLRP3/caspase-1/GSDMD-mediated pyroptosis exerts a crucial role in astrocyte pat [PMID:34877938] Li S, Sun Y, Song M, Song Y, Fang Y, Zha JCI insight 2021 0
NLRP3 inflammasome activation drives tau pathology. [PMID:31748742] ["Ising C", "Venegas C", "Zhang S", "Sch Nature 2019 0
Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodeg [PMID:30381407] Gordon R, Albornoz EA, Christie DC, Lang Science translational medicine 2018 0
NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS [PMID:23254930] Heneka MT, Kummer MP, Stutz A, Delekate Nature 2013 0
NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS [PMID:23254930] ["Heneka Michael T", "Kummer Markus P", Nature 2013 0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning Proteinopathy in their description or question text

Dual Proteinopathy Clearance via Enhanced Drainage

Score: 0.000 · unknown disease · 2026-04-28

Therapeutic enhancement of perivascular drainage to simultaneously address multiple proteinopathies through restored bul